Propiedad y actividad de insiders de Skye Bioscience, Inc. (SKYE): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $1.70 |
| Capitalización | $7M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-08-18 | Schwab Andrew J. | S-Sale | 253,080 | $96K |
| 2026-08-19 | Schwab Andrew J. | S-Sale | 57,476 | $20K |
| 2026-08-20 | Schwab Andrew J. | S-Sale | 6,495 | $2K |
| 2026-08-18 | Schwab Andrew J. | S-Sale | 45,090 | $17K |
| 2026-08-19 | Schwab Andrew J. | S-Sale | 10,255 | $4K |
| 2026-08-20 | Schwab Andrew J. | S-Sale | 1,159 | $371 |
| 2026-08-18 | Schwab Andrew J. | S-Sale | 1,830 | $695 |
| 2026-08-19 | Schwab Andrew J. | S-Sale | 409 | $143 |
| 2026-08-20 | Schwab Andrew J. | S-Sale | 46 | $15 |
| 2026-08-18 | 5AM Partners VII, LLC | S-Sale | 253,080 | $96K |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $64820 | $259955 | $1.9M | $1.8M | $2.5M | $9.0M | $1.2M | $1.3M | $68.4M | $5.9M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $19.9M |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | $74121 | $158242 | $5065 | $10474 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $279489 | $555811 | $2.0M | $2.0M | $2.7M | $9.6M | $8.9M | $11.7M | $70.8M | $27.1M |
| Inmovilizado Material | $9584 | $1407 | $3445 | $1983 | $7341 | $234682 | $159045 | $281259 | $1.9M | $1.2M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $323363 | $557218 | $2.0M | $2.0M | $2.7M | $9.9M | $9.1M | $11.9M | $72.8M | $28.3M |
| Cuentas por Pagar | $274650 | $100921 | $15597 | $139809 | $381372 | $900010 | $1.8M | $956754 | $569252 | $2.0M |
| Deuda a Corto | 0 | $235000 | 0 | 0 | $64062 | $2.0M | $1.9M | $4.4M | 0 | 0 |
| Pasivos Corrientes | $661958 | $805974 | $15.9M | $970818 | $787199 | $3.9M | $12.1M | $13.9M | $4.3M | $8.2M |
| Deuda a Largo | 0 | 0 | $1.4M | $387070 | $1.4M | 0 | 0 | 0 | 0 | $83999 |
| Pasivos Totales | $1.8M | $1.4M | $17.5M | $1.4M | $2.2M | $4.0M | $12.1M | $14.1M | $4.6M | $8.3M |
| Reservas | -$10.9M | -$14.0M | -$33.2M | -$32.2M | -$38.7M | -$47.3M | -$66.7M | -$104.4M | -$130.9M | -$186.9M |
| Patrimonio Neto | -$1.5M | -$800078 | -$15.6M | $548058 | $450786 | $5.9M | -$3.0M | -$2.1M | $68.2M | $20.0M |
| Deuda Total | 0 | $235000 | $1.4M | $387070 | $1.5M | $2.1M | $2.0M | $4.6M | $455590 | $273646 |
| Deuda Neta | -$64820 | -$24955 | -$492413 | -$1.4M | -$971607 | -$6.8M | $737999 | $3.4M | -$68.0M | -$25.5M |
| Capital Circulante | -$382469 | -$250163 | -$14.0M | $1.0M | $1.9M | $5.7M | -$3.2M | -$2.3M | $66.5M | $18.9M |
Salud financiera
| Deuda / Patrimonio | 0.01 |
| Ratio corriente | 3.30 |
Rentabilidad
| Rentabilidad sobre capital | -279.29% |
| Rentabilidad sobre capital invertido | -286.55% |
| Rentabilidad sobre activos | -197.52% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Empresas relacionadas: ALGS · BRNS · CVM · INMB · KZR · LVTX · MRSN
Explorar sector: Healthcare · Biotechnology
Más secciones de SKYE: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones